Living Life With Diabetes

Anti-Inflammatory Drug Improves Glycemia

A press release form the ADA,The American Diabetes Association says that a new drug may help reduce the risks for diabetes in obese young adults by reducing glycemia and lowering inflammation.

A study that is being published in the February issue of Diabetes Care finds that a drug that is similar to aspirin called Salsalate can help obese young adults with problems of glycemia and inflammation.

“Salsalate – a nonsteroidal, anti-inflammatory medication similar to
aspirin that does not cause bleeding – has been used for decades to
reduce the pain of rheumatoid arthritis. This double-masked,
placebo-controlled study found that salsalate substantially reduced
glycemia as well as inflammation in obese, young adults, thereby likely
reducing the risk of developing type 2 diabetes and heart disease.”

(American Diabetes Association)

It has been well known throughout the medical community that high doess of aspirin may reduce blood glucose levels. The mechanisms behind this effect have not been understood and testing on human subjects are far to dangerous due to chances of stomach bleeding associated with this treatment.

The study found that people who took 4 grams per day of salsalate reduced fasting glucose levels by 13% and C-reactive protein concentrations by 34%. C-reative proteins are a marker of inflammation.

Although the results of this study was conducted on a small population, it was encouraging enough to solicit funds from the National Institute of Health for further larger studies.

For More Information about the ADA click HERE

Source: ADA www.diabetes.org

Powered by ScribeFire.